SELECT: The selenium and vitamin E cancer prevention trial

Urologic Oncology: Seminars and Original Investigations

Volumn 21, Issue 1, 2003, Pages 59-65

  Klein, Eric A ^a   Thompson, Ian M ^b   Lippman, Scott M ^c   Goodman, Phyllis J ^d   Albanes, Demetrius ^e   Taylor, Philip R ^e   Coltman, Charles ^f  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d USA   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f Southwest Oncology Group   (United States)

Author keywords

Chemoprevention; Prostate cancer; Selenium; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; SELENIUM; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ENZYME INHIBITOR; FINASTERIDE; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; CANCER PREVENTION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; ADENOCARCINOMA; BLOOD; COMPARATIVE STUDY; INCIDENCE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATIENT SELECTION; PROSTATE TUMOR; REVIEW; RISK; STANDARD;

ADENOCARCINOMA; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FINASTERIDE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTICENTER STUDIES; PATIENT SELECTION; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RISK; SELENIUM; TUMOR MARKERS, BIOLOGICAL; VITAMIN E;

EID: 0141922731     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(02)00301-0     Document Type: Conference Paper

References (56)

1. Ries LAG, Kosary CL, Hankey BF, Miller BA, Edwards BK, editors. SEER Cancer Statistics Review, 1973-1995, National Cancer Institute. Bethesda, MD, 1998.
2. Heinonen OP, Albanes D, Huttunen JK, et al. Prostate cancer and supplementation with alpha-tocopherol and β-carotene: incidence and mortality in a controlled trial. JNCI 1998;90:440-6.
3. Clark LC, Combs Jr GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;276:1957-63.
4. National Academy of Sciences. Recommended Dietary Allowances. 10th ed. Washington, DC: National Academy Press, 1989, 217-24.
5. Combs Jr GF, Clark LC. Selenium and cancer. In: Garewal H, editor. Antioxidants and disease prevention. New York: CRC Press; 1997.
6. Nakamura A, Shirai T, Takahashi S, Ogawa K, Hirose M, Ito N. Lack of modification by naturally occurring antioxidants of 3,2′-dimethyl-4- aminobiphenyl initiated rate prostate carcinogenesis. Cancer Letters 1991;58:241-6.
7. Webber MM, Perez-Ripoli EA, James GT. Inhibitory effects of selenium on the growth of DU-145 human prostate carcinoma cells in vitro. Biochemical and Biophysical Research Communications 1985; 130:603-9.
8. Ip C, Medina D. Current concept of selenium and mammary tumor-igenesis. In: Medina D, Kidwell W, Heppner G, Anderson EP, editors. Cellular and molecular biology of breast cancer. New York: Plenum Press; 1987, p. 479.
9. Kiremidjian-Schumacher L, Stotzky G. Review: selenium and immune response. Environmental Res 1987;42:277-303.
10. Thompson HJ, Wilson A, Lu J, et al. Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis 1994;15:183-6.
11. Redman C, Scott JA, Baines AT, Basye JL, Clark LC, Calley C, Roe D, Payne CM, Nelson MA. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Letters 1998;125:103-10.
12. Shimada T, El-Bayoumy K, Upadhyaya P, Sutter TR, Guengerich FP, Yamazaki H. Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds. Cancer Res 1997;57:4757-64.
13. El-Bayoumy K. The role of selenium in cancer prevention. In: DeVita VT, Hellman S, Rosenberg SS, editors. Practice of oncology. Philadelphia: Lippincott; 1991, p. 1-15.
14. Bedwal RS, Nair N, Sharma MP, Mathur RS. Selenium-its biological perspectives. Medical Hypotheses 1993;41:150-9.
15. Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219-24.
16. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF, Gail M, Li GY, Yu Y, Liu BQ, Tangrea J, Sun YH, Liu F, Fraumeni Jr JF, Zhang YH, Li B. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-92.
17. Li JY, Taylor PR, Li B, Dawsey S, Wang GQ, Ershow AG, Guo W, Liu SF, Yang CS, Shen Q, Wang W, Mark SD, Zou XN, Greenwald P, Wu YP, Blot WJ. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 1993;85:1492-8.
18. Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 1998;81:730-4.
19. Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 1922;56:650-1.
20. Burton GW, Ingold KU. Autoxidation of biological molecules. 1. The antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J Am Chem Soc 1981;103:6472.
21. Machlin LJ. Vitamin E. In: Machlin LJ, editor. Handbook of vitamins. 2nd ed. New York: Marcel Dekker; 1991.
22. Pappas AM. Vitamin E: tocopherols and tocotrienols. In: Pappas AM, editor. Antioxidant status, diet, nutrition, and health. Boca Raton: CRC; 1998.
23. Azzi A, Boscoboinik D, Marilley D, Ozer NK, Stauble B, Tasinato A. Vitamin E: a sensor and an information transducer of the cell oxidation state. Am J Clin Nutr 1995;62:1337s-46s.
24. Mahoney CW, Azzi A. Vitamin E inhibits protein kinase C activity. Biochem Biophys Res Commun 1988;154:694-7.
25. Chatelain E, Boscoboinik DO, Bartoli GM, et al. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim Biophys Acta 1993;1176:83-9.
26. Ottino P, Duncan JR. Effect of alpha-tocopherol succinate on free radical and lipid peroxidation levels in BL6 melanoma cells. Free Radic Biol Med 1997;22:1145-51.
27. Wang W, Higuchi CM. Induction of NAD(P)H:quinone reductase by vitamins A, E and C in Colo205 colon cancer cells. Cancer Lett 1995;98:63-9.
28. Traber MG, Packer L. Vitamin E: beyond antioxidant function. Am J Clin Nutr 1995;62:1501s-9s.
29. Israel K, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways. Nutr Cancer 1995;24(2):161-9.
30. Kishimoto M, Yano Y, Yajima S, Otani S, Ichikawa T, Yano T. The inhibitory effect of vitamin E on 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone-induced lung tumorigenesis in mice based on the regulation of polyamine metabolism. Cancer Lett Apr 24 1998;126(2):173-8.
31. Sigounas G, Anagnostou A, Steiner M. d1-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr Cancer 1997;28(1):30-5.
32. Umeda F, Kato K-I, Muta K, Ibayashi H. Effect of vitamin E on function of pituitary-gonadal axis in male rats and human studies. Endocrin Japon 1982;29:287-92.
33. USDA (U.S. Department of Agriculture). Nationwide food consumption survey continuing survey of food intake by individuals: women 19-50 years and their children 1-5 years, 4 days, 1985. Report No. 85-4, Nutrition and Monitoring Division, Human Nutrition Information Economic Research Service, U.S. Department of Agriculture, Hyattsville, MD, 1987.
34. USDA (U.S. Department of Agriculture). Nationwide food consumption survey continuing survey of food intake by individuals: men 19-50 years 1 day, 1985, Report No. 85-3, Nutrition and Monitoring Division, Human Nutrition Information Economic Research Service, U.S. Department of Agriculture, Hyattsville, MD, 1987.
35. National Research Council (NRC). Recommended Dietary Allowances. 10th edition. Washington, D.C.: National Academy Press, 1989.
36. Comstock GW, Bush TL, Helzlsouer K. Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 1992;135:115-21.
37. Shibata A, Paganini-Hill A, Ross RK, Henderson BE. Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br J Cancer 1992;66:673-9.
38. Yong LC, Brown CC, Schatzkin A, et al. Intake of vitamins E, C, and A and risk of lung cancer: the NHANES I Epidemiologic Followup study. Am J Epidemiol 1997;146:231-43.
39. Ocke MC, Bueno-de-Mesquita HB, Feskens EJ, et al. Repeated measurements of vegetables, fruits, b-carotene, and vitamins C and E in relation to lung cancer: The Zutphen study. Am J Epidemiol 1997; 145:358-65.
40. Knekt P, Jarvinen R, Sepannen R, et al. Dietary antioxidants and the risk of lung cancer. Am J Epidemiol 1991;134:471-9.
41. Longnecker MP, Martin-Moreno JM, Knekt P, et al. Serum alphatocopherol concentration in relation to subsequent colorectal cancer: pooled data from five cohorts. JNCI 1992;84:430-5.
42. Wu AH, Paganini-Hill A, Ross RK, Henderson BE. Alcohol, physical activity and other factors for colorectal cancer: a prospective study. Br J Cancer 1987;55:687-94.
43. Bostick RM, Potter JD, McKenzie DR, et al. Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res 1993;53:4230-7.
44. Ferraroni M, La Vecchia C, D'Avanzo B, et al. Selected micronutrient intake and the risk of colorectal cancer. Br J Cancer 1994;70: 1150-5.
45. Lee HP, Gourley L, Duffy SW, et al. Colorectal cancer and diet in an Asian population study among Singapore Chinese. Int J Cancer 1989; 43:1007-16.
46. Freudenheim JL, Graham S, Horvath PJ, et al. Risks associated with source of fiber components in cancer of the colon and rectum. Cancer Res 1990;50:3295-300.
47. Meyer F, White E. Alcohol and nutrients in relation to colon cancer in middle-aged adults. Am J Epidemiol 1993;136:225-36.
48. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States. J Natl Cancer Inst 1981;66:1192-308.
49. Comstock GW, Helzlsouer KJ, Bush TL. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr 1991;53:260S-4S.
50. Knekt P, Aromaa A, Maatala J, et al. Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol 1988;127:28-41.
51. Hsing AW, Comstock GW, Abbey H, Polk BF. Serologic precursors of cancer retinol, carotenoids, and tocopherol and risk of prostate cancer. JNCI 1990;82:941-6.
52. Eichholzer M, Stahelin HB, Gey FK, et al. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer 1996;55:145-50.
53. Hartman TJ, Albanes D, Pietinen P, et al. The association between baseline vitamin E, selenium, and prostate cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers Prev 1998;7:335-40.
54. Rohan TE, Howe GR, Burch ID, et al. Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada. Cancer Causes Control 1995;6:145-54.
55. The ATBC Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
56. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.